Short Interest in Hypermarcas (OTCMKTS:HYPMY) Drops By 100.0%

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 13th, there was short interest totaling 16 shares, a decrease of 100.0% from the January 29th total of 50,686 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 90,351 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 90,351 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.Hypermarcas Price PerformanceShares of HYPMY traded up $0.10 during trading hours on Wednesday, reaching $4.50. 11,905 shares of the stock traded hands, compared to its average volume of 33,058. The company has a market cap of $2.85 billion, a P/E ratio of 19.57 and a beta of 0.71. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. The company's 50-day moving average price is $4.48 and its two-hundred day moving average price is $4.42. Hypermarcas has a 52-week low of $3.10 and a 52-week high of $5.50. Hypermarcas Company Profile (Get Free Report)Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors. Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.Read MoreFive stocks we like better than HypermarcasThe gold chart Wall Street is terrified of…America’s 1776 happening againThis makes me furiousBuy this Gold Stock Before May 2026What a Former CIA Agent Knows About the Coming CollapseThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Hypermarcas Right Now?Before you consider Hypermarcas, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.While Hypermarcas currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here